The pentose phosphate pathway is a branch of the glycolytic pathway that not only produces ribonucleotides but is also a major source of NADPH. The pentose phosphate pathway consists of an oxidative branch that produces NADPH and ribonucleotides and a non-oxidative branch that recruits intermediate metabolites of glycolysis. Numerous studies have demonstrated that cancer directly or indirectly modulates the flux of the pentose phosphate pathway, thereby affecting the flux of glucose in glycolysis, the tumor microenvironment, and the proliferation of cancer cells. Therefore, studying the pentose phosphate pathway is crucial for a comprehensive understanding of cancer glucose metabolism, and can bring new hope for cancer treatment.
CD BioGlyco can provide based on the MOPCGM platform comprehensive analysis services of glucose metabolism in the cancer pentose phosphate pathway, including quantitative analysis of metabolites in the pentose phosphate pathway, expression of metabolism-related enzymes, and mutation of metabolism-related genes.
CD BioGlyco provides analysis services specifically for glucose metabolism in the PPP, including PPP-related gene mutation analysis, quantitative detection services for metabolites, enzyme expression, activity analysis, post-translational modification analysis services, and metabolic flux analysis services. Our experienced teams of scientists, researchers, and technicians provide fast turnaround, high-quality services at competitive prices for worldwide customers. Our customers have direct access to our staff and prompt feedback on their inquiries. If you are interested in our services, please contact us for more details.
